Predilatation for transcatheter aortic valve replacement: Still have a role?
Mehmet CilingirogluKonstantinos MarmagkiolisPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2020)
Predilation with a balloon aortic valvuloplasty (BAV) was the standard of care for transcatheter aortic valve replacement (TAVR) until recently. Both the operators increased experiences as well as smaller device sizes and improved device designs have much improved omitting the use of BAV in majority of the cases in today's clinical practice. Predilation with BAV seems to help in selected group of patients with severe aortic leaflet calcium volumes to avoid post-dilation.
Keyphrases
- transcatheter aortic valve replacement
- aortic valve
- aortic stenosis
- transcatheter aortic valve implantation
- clinical practice
- healthcare
- palliative care
- mental health
- quality improvement
- early onset
- pain management
- pulmonary hypertension
- coronary artery disease
- mitral valve
- pulmonary artery
- ejection fraction
- health insurance